Skip to content

Clinical trials

Phase 2 Recurrence trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2 Country / region: France Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20067
20073
20082
20098
20101
20112
20126
20138
20145
20154
20162
20174
20188
20196
20206
20217
20225
20233
20242
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Terminated15
Recruiting10
Active, not recruiting10
Not yet recruiting4
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Celgene6
ARCAGY/ GINECO GROUP5
AstraZeneca5
UNICANCER5
The Lymphoma Academic Research Organisation4
Amgen3
Centre Leon Berard3
Groupe Oncologie Radiotherapie Tete et Cou3
Merck Sharp & Dohme LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence106
Neoplasm Metastasis19
Lymphoma, Non-Hodgkin11
Multiple Myeloma11
Lymphoma, Large B-Cell, Diffuse10
Neoplasms10
Leukemia8
Squamous Cell Carcinoma of Head and Neck8
Head and Neck Neoplasms7
Leukemia, Lymphocytic, Chronic, B-Cell7

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.